An afternoon of talks on the physiology of interactions between the nervous and immune systems.

13.00: Welcome
13.05: Christopher Buckley (Stromal Cell Biology, Kennedy Institute of Rheumatology), ‘Inflammation, damage or pain: Fibroblasts decide’
13.25: Franziska Denk (Wolfson Centre for Age-Related Diseases, King’s College London), ‘Neuro-immune interactions in chronic pain – are nerves really to blame?’ 13.45: 5 min break
13.50: Shuaiwei Wang (Neural Injury, Clinical Neurosciences), ‘Immune cell profiling of peripheral nerve injury: bridging mouse models and human patients’
14.05: Pao Sheng-Chang (Neural Injury, Clinical Neurosciences), ‘Understanding neuro-immune interactions in humans and humanised model system’
14.20: Gitalee Sarker (Metabolism & Endocrinology, Dept. Physiology, Anatomy and Genetics), ‘Sympathetic Neuro-Adipose Crosstalk in Obesity’
14.35: Monica Olcina (Immune Radiation Biology, Department of Oncology), ‘Investigating selective pressures in immunosuppressive tumour microenvironments to identify therapeutic targets’
14.50: Donal Skelly (Centre for Neuroinflammation, Clinical Neurosciences), ‘Peripheral-Central Neuro-immune interactions in Degenerative disease’
15.05: Bjorn Vahsen (Motor Neuron Disease Centre, Clinical Neurosciences), ‘Investigating the role of microglia in amyotrophic lateral sclerosis using human iPSC models’
15.20: 10 min break
15.30: Lahiru Handunnetthi (Wellcome Centre for Human Genetics), ‘Mechanistic insights into CNS infections and subsequent neurological disease’
15.45: Christine Strippel (Autoimmune Neurology, Clinical Neurosciences), ‘T cells in GAD65-autoantibody associated neurological syndromes’
16.00: Bo Sun (Autoimmune Neurology, Clinical Neurosciences), ‘The role of B cell tolerance in the pathogenesis of CASPR2 antibody encephalitis’
16.15: Adham Farah (Neural Injury, Clinical Neurosciences), ‘LGI1, the target of autoantibodies from pain patients, contributes to pathological pain in mouse models’
16.30: Sophie Binks (Autoimmune Neurology, Clinical Neurosciences), ‘Beyond the MHC: new risk loci in LGI1-antibody-encephalitis’
16.45: Panel discussion
17.00: Close